Skip to main content
. 2021 Jun 30;26(10):1977–1985. doi: 10.1007/s10147-021-01973-1

Table 3.

Pharmacokinetic parameters

Parameter Trabectedin Doxorubicin
Level 1 (n = 6) Level 2 (n = 12) Level 1 (n = 6) Level 2 (n = 12)
tmax, h 2.68 ± 0.94 2.78 ± 0.66 4.38 ± 1.70 4.37 ± 1.80
Cmax, *pg/mL or **µg/mL 8640 ± 1320* 9890 ± 3150* 19.8 ± 1.7** 22.2 ± 3.0**
AUC0–inf, *ng·h/mL or **µg·h/mL 61.5 ± 7.4* 83.7 ± 69.0* 2542.0 ± 391.2** 1941.2 ± 548.3**
t½, h 102.8 ± 27.8 124.9 ± 100.2 92.0 ± 15.3 61.0 ± 12.7
CL, *L/h or **mL/h 21.5 ± 2.2* 26.8 ± 9.3* 17.7 ± 3.4** 26.9 ± 9.1**
Vdss, L 1461 ± 456 1921 ± 727 2.26 ± 0.27 2.15 ± 0.35

All data are expressed as mean ± SD

AUC0–inf area under the concentration–time curve from zero to infinity, CL clearance, Cmax maximum concentration, SD standard deviation, t½ terminal half-life, tmax time to Cmax, Vdss volume of distribution at steady state